000 01416 a2200457 4500
005 20250513192929.0
264 0 _c19991014
008 199910s 0 0 eng d
022 _a0041-1345
024 7 _a10.1016/s0041-1345(99)00366-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVila, A
245 0 0 _aAcyclovir prophylaxis of cytomegalovirus disease in kidney transplant recipients.
_h[electronic resource]
260 _bTransplantation proceedings
_cSep 1999
300 _a2335-6 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAcyclovir
_xtherapeutic use
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aCytomegalovirus Infections
_xepidemiology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aKidney Transplantation
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPostoperative Complications
650 0 4 _aRetrospective Studies
700 1 _aGuirado, L L
700 1 _aBalius, A
700 1 _aDíaz, M
700 1 _aBaró, E
700 1 _aOlaya, M
700 1 _aAndrade, M
700 1 _aAgraz, I
700 1 _aSolá, R
773 0 _tTransplantation proceedings
_gvol. 31
_gno. 6
_gp. 2335-6
856 4 0 _uhttps://doi.org/10.1016/s0041-1345(99)00366-8
_zAvailable from publisher's website
999 _c10457769
_d10457769